RIB - Recherche et innovation en biotechnologie
Vers la preuve d'efficacité chez l'homme de la thérapie matricielle basée sur les RGTA ® pour traiter la parodontitie. – Glycoregenperodont
Project coordination
Denis BARRITAULT (PME (petite et moyenne entreprise))
The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.
Partner
Help of the ANR 448,060 euros
Beginning and duration of the scientific project:
- 36 Months
